ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 016,65
-0,93%
Dow Jones
38 085,80
-0,98%
DAX
17 917,28
-0,87%
Brent Oil
88,145
1,06%
Bitcoin
64 751,24
0,70%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Gsk Plc (GSK)

  7. Gsk Plc (GSK) Actualités

GSK Gsk Plc

1 640,50
4,50 (0,28%)
25 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Gsk Plc GSK London Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
4,50 0,28% 1 640,50 17:29:57
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1 642,00 1 635,00 1 656,00 1 640,50 1 636,00
plus d'informations sur les cotations »
Secteur Industriel
PHARMACEUTICALS & BIOTECHNOLOGY

Actualités Recentes

Date Heure Source Titre
24/4/202410:14ALNCNewsGSK's Jemperli with chemotherapy accepted for priority..
24/4/202408:00UK RNSGSK PLC US FDA accepts new indication filing for Jemperli
19/4/202416:30UK RNSGSK PLC Director/PDMR Shareholding
17/4/202416:30UK RNSGSK PLC Director/PDMR Shareholding
17/4/202409:46ALNCNewsTOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea..
17/4/202408:05UK RNSGSK PLC GSK announces additional EAGLE-1 results
17/4/202408:00UK RNSGSK PLC Results from long-term data relating to Shingrix
16/4/202415:11UK RNSGSK PLC Amendment - Director/PDMR Shareholding
16/4/202409:59ALNCNewsGSK's latest meningitis vaccine accepted for review by US..
16/4/202408:00UK RNSGSK PLC FDA accepts GSK meningitis vaccine candidate file
15/4/202416:30UK RNSGSK PLC Director/PDMR Shareholding
08/4/202411:27ALNCNewsIN THE KNOW: Barclays ups GSK price target but HIV drug..
04/4/202413:05UK RNSGSK PLC Replacement - Total Voting Rights
02/4/202416:00UK RNSGSK PLC Total Voting Rights
26/3/202416:30UK RNSGSK PLC Director/PDMR Shareholding
25/3/202414:00UK RNSGSK PLC Notice of AGM
22/3/202417:20UK RNSGSK PLC Transfer of Treasury Shares
22/3/202416:36UK RNSGSK PLC Director/PDMR Shareholding
18/3/202410:30UK RNSGSK PLC New Phase III Jemperli data in endometrial cancer
18/3/202409:47ALNCNewsGSK says Jemperli combination gets good results for..
13/3/202416:48UK RNSGSK PLC Director/PDMR Shareholding
08/3/202418:12UK RNSGSK PLC Board Committee Change
07/3/202410:38ALNCNewsGSK observes positive data in Blenrep trial for blood cancer..
07/3/202408:00UK RNSGSK PLC GSK announces positive Blenrep DREAMM-8 results
06/3/202417:00UK RNSGSK PLC ViiV LAI vs oral SOC data in adherence-challenged
05/3/202418:24UK RNSGSK PLC GSK Annual Report 2023 on Form 20-F
05/3/202412:03ALNCNewsGSK says ViiV's cabotegravir study supports longer HIV dose..
05/3/202408:00UK RNSGSK PLC New ViiV LA formulation potential 4-month dosing
01/3/202416:00UK RNSGSK PLC Total Voting Rights
01/3/202413:15UK RNSGSK PLC GSK publishes Annual Report 2023
29/2/202410:44ALNCNewsTOP NEWS: GSK avoids "protracted litigation" with Zantac..
29/2/202408:05UK RNSGSK PLC Directorate Change
29/2/202408:00UK RNSGSK PLC Statement: Zantac (ranitidine) litigation
26/2/202416:30UK RNSGSK PLC Director/PDMR Shareholding
26/2/202409:25ALNCNewsGSK gonorrhoea treatment achieves efficacy endpoint in..
26/2/202408:00UK RNSGSK PLC GSK announces positive EAGLE-1 headline results
22/2/202416:30UK RNSGSK PLC Director/PDMR Shareholding
21/2/202410:47ALNCNewsGSK reports encouraging results for ViiV's Cabenuva HIV..
21/2/202408:00UK RNSGSK PLC ViiV LAI superior to orals in adherence-challenged
20/2/202410:01UK RNSGSK PLC Julie Brown - External Appointment
19/2/202416:30UK RNSGSK PLC Director/PDMR Shareholding
15/2/202416:32UK RNSGSK PLC Director/PDMR Shareholding
15/2/202409:49ALNCNewsGSK completes USD1.4 billion purchase of respiratory firm..
15/2/202408:00UK RNSGSK PLC GSK completes acquisition of Aiolos Bio
13/2/202417:45UK RNSGSK PLC Director/PDMR Shareholding - Replacement
13/2/202416:40UK RNSGSK PLC Director/PDMR Shareholding
13/2/202416:35UK RNSGSK PLC Director/PDMR Shareholding
13/2/202416:30UK RNSGSK PLC Director/PDMR Shareholding
13/2/202409:25ALNCNewsIN THE KNOW: Citi turns positive on GSK after seven years on..
12/2/202416:39UK RNSGSK PLC Director/PDMR Shareholding

Dernières Valeurs Consultées

LSE
GSK
Gsk
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés